Atlas Trials

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

Clinical trial NCT03681938 · UNKNOWN

Trial details

NCT number
NCT03681938
Sponsor
Institut Paoli-Calmettes
Status
UNKNOWN
Study type
OBSERVATIONAL
Lymphoma, B-Cell
Start date
2017-07-03
Primary completion
2019-07-28
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.